Sanofi-Aventis SA offered to buy Genzyme Corp. for $69 a share, or about $18.5 billion in cash.
See the original post here:
Sanofi Offers $18.5 Billion in Cash for Genzyme
Sanofi-Aventis SA offered to buy Genzyme Corp. for $69 a share, or about $18.5 billion in cash.
See the original post here:
Sanofi Offers $18.5 Billion in Cash for Genzyme
Sanofi-Aventis SA said it is offering to buy Genzyme Corp. for $69 a share, or about $18.5 billion in cash. The Paris-based drugmaker commented on the bid in an e-mailed statement today.
Read the original here:
Sanofi Offers to Buy Genzyme for $18.5 Billion in All-Cash Deal
U.S. stocks rose, almost wiping out the Dow Jones Industrial Average’s 2010 loss, after speculation that Genzyme Corp. may be bought spurred optimism that a rebound in acquisitions is accelerating and General Electric Co. boosted its dividend.
View original post here:
U.S. Stocks Rise on Genzyme Takeover Speculation, GE’s Dividend
U.S. stocks rallied, with the Dow Jones Industrial Average erasing its 2010 loss, as reports that Genzyme Corp. has been approached with a takeover offer spurred optimism a rebound in mergers and acquisitions is accelerating.
Visit link:
Dow Erases 2010 Loss as Stocks Rally